Correlation Engine 2.0
Clear Search sequence regions

  • angina (1)
  • behavior (1)
  • diet (1)
  • humans (1)
  • hydroxymethylglutaryl coa (2)
  • ischaemia (1)
  • patients (2)
  • platelet (2)
  • smoking (1)
  • Sizes of these terms reflect their relevance to your search.

    Revascularisation strategies involving coronary artery bypass grafting or percutaneous interventions are the main treatments for stable coronary artery disease, particularly for patients with ongoing symptoms despite medical therapy and/or extensive ischaemia as demonstrated by either non-invasive or invasive means. Irrespective of whether revascularisation is being undertaken, all patients with stable coronary disease require optimal medical therapy in order to reduce the risk of subsequent adverse cardiac events, particularly acute myocardial infarction. The role of medical management has been very actively investigated and reported, particularly because of the global disease burden and the associated high morbidity and mortality. In this review, the current available medical management for the treatment of coronary atherosclerosis is described together with the role and prospects of the newer classes of drugs that are coming into use, and future perspectives in this field.


    P Pellicori, P Costanzo, A C Joseph, A Hoye, S L Atkin, J G F Cleland. Medical management of stable coronary atherosclerosis. Current atherosclerosis reports. 2013 Apr;15(4):313

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 23423522

    View Full Text